These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5628203)

  • 1. [Study on the fractionation of urinary 17-ketosteroids in the field of urology. VI. Urinary 17-ks fractions after testosterone administration and long-term treatment of testosterone propionate in male hypogonadism].
    Sonoda T
    Nihon Hinyokika Gakkai Zasshi; 1967 Nov; 58(11):1134-45. PubMed ID: 5628203
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study on androgen in urological fields. Study on urinary 17-ketosteroid fractions and testosterone radioactivity].
    Takata M
    Nihon Hinyokika Gakkai Zasshi; 1970 Feb; 61(2):135-51. PubMed ID: 5462391
    [No Abstract]   [Full Text] [Related]  

  • 3. [Excretion of free and glucuronoside-conjugated epitestosterone and testosterone in children].
    Schollberg K; Seiler E; Hinkel GK
    Z Kinderheilkd; 1968 May; 102(4):341-5. PubMed ID: 5708165
    [No Abstract]   [Full Text] [Related]  

  • 4. Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.
    Horký K; Küchel O; Gregorvá I; Stárka L
    J Clin Endocrinol Metab; 1969 Feb; 29(2):297-9. PubMed ID: 4236926
    [No Abstract]   [Full Text] [Related]  

  • 5. [Testosterone excretion in various forms and grades of severity of endocrine testicular insufficiency].
    Schmidt H; Starcevic Z
    Klin Wochenschr; 1967 Apr; 45(7):377-82. PubMed ID: 5585316
    [No Abstract]   [Full Text] [Related]  

  • 6. [Excretion of testosterone, epitestosterone and androstenedione before and after HCG administration in normal men and patients with primary and secondary hypogonadism].
    Hubl W; Siebert W; Büchner M; Hering H
    Endokrinologie; 1971 Jun; 58(1):62-74. PubMed ID: 5561793
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of the urinary LH concentration in normal men and in men suffering from primary and secondary hypogonadism (statistical analysis of the results).
    Alicicco E; Franchi F; Barletta D; Argenio G; Tognaccini D; Romanelli R; Luisi M
    Folia Endocrinol; 1973 Jun; 26(3):165-74. PubMed ID: 4740898
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kallman's syndrome--hypogonadism and anosmia].
    Pulli K; Pelkonen R
    Duodecim; 1975; 91(10):649-56. PubMed ID: 1080706
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary testosterone response to human chorionic gonadotropin. Evaluation of male patients with hypogonadotropic hypogonadism.
    Fariss BL; Cerchio GM; Di Raimondo VC
    Fertil Steril; 1969; 20(4):632-8. PubMed ID: 5795042
    [No Abstract]   [Full Text] [Related]  

  • 10. [Letter: Testosterone suppositories DAK].
    Hamburger C
    Ugeskr Laeger; 1974 Feb; 136(6):307-8. PubMed ID: 4820554
    [No Abstract]   [Full Text] [Related]  

  • 11. Testosterone undecanoate: a new orally active androgen.
    Hirschhäuser C; Hopkinson CR; Sturm G; Coert A
    Acta Endocrinol (Copenh); 1975 Sep; 80(1):179-87. PubMed ID: 1098350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnostic significance of testosterone, 17-ketosteroids and estrogen secretion in male hypogonadism].
    Schmidt H; Starcevic Z
    Klin Wochenschr; 1965 Dec; 43(23):1271-3. PubMed ID: 4224700
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study on the fractionation of urinary 17-ketosteroids in the field of urology. I. The fractionation of urinary 17-ketosteroids in healthy men].
    MORIMOTO J; KAWAKURA K; MATUMURA M
    Nihon Hinyokika Gakkai Zasshi; 1962 Jul; 53():509-15. PubMed ID: 14476072
    [No Abstract]   [Full Text] [Related]  

  • 14. [17-ketosteroid changes in breast cancer during testosterone propionate treatment].
    Mindlin SS; Smiller RR
    Vopr Onkol; 1970; 16(7):17-20. PubMed ID: 5482837
    [No Abstract]   [Full Text] [Related]  

  • 15. [Study on the fractionation of urinary 17-ketosteroids in the field of urology. II. The fractionation of urinary 17-ketosteroids in the patients of prostatic cancer].
    MORIMOTO J
    Nihon Hinyokika Gakkai Zasshi; 1962 Jul; 53():516-30. PubMed ID: 14476073
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of exogenous testosterone on the excretion of luteinizing and follicle-stimulating hormones in hypogonadism].
    Demchenko AN; Serdechnaia LI
    Probl Endokrinol (Mosk); 1980; 26(4):32-7. PubMed ID: 6774329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous and exogenous testosterone levels after administration of deuterium-labelled testosterone propionate in hypogonadotropic hypogonadism.
    Fujioka M; Shinohara Y; Baba S; Irie M; Inoue K
    Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3100-1. PubMed ID: 2632058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estrogen excretion in men with various forms of hypogonadism in the late periods after the use of hormone therapy].
    Demchenko AN; Laskavaia AI; Palienko AI
    Vrach Delo; 1980 Sep; (9):98-100. PubMed ID: 7423967
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of aminoglutethimide on extraglandular metabolism of exogenous testosterone.
    Horky K; Kuchel O; Stárka L; Gregorová I
    Metabolism; 1971 Mar; 20(3):331-6. PubMed ID: 4251108
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the behavior of C-19 INH reacting steroid fractions in hypogonadal subjects under basal conditions and after gonadotropin stimulation].
    Maglione S; Aurilia MG; Brancaccio A; D'Alessandro B
    Boll Soc Ital Biol Sper; 1964 Sep; 40(17):1022-4. PubMed ID: 4381649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.